A COVID-19 vaccine candidate developed by the company Moderna and the NIH begins its final phase of testing today. It could take as many as 30,000 volunteers — and the entire process will likely take months.
Biotech company Moderna, headquartered in Cambridge, Massachusetts, announced today that it is beginning Phase 3 trials of its COVID-19 vaccine. It will enroll up to 30,000 volunteers.Biotech company Moderna, headquartered in Cambridge, Massachusetts, announced today that it is beginning Phase 3 trials of its COVID-19 vaccine. It will enroll up to 30,000 volunteers.The COVID-19 vaccine candidate made by the U.S. biotech company Moderna, Inc.
This phase is called Phase 3 efficacy testing and it is designed to see if the vaccine actually prevents disease. Up to 30,000 volunteers will be assigned to one of two groups. One group will receive two injections spaced approximately 28 days apart of mRNA-1273, as the vaccine is known. The other group will receive an injection containing only salt water.
be approximately 150 cases of COVID-19 among study participants to say with confidence that the vaccine is actually preventing disease. How long it takes to reach that number, and how many participants will have to be enrolled in the study, is an open question. It depends in part on how much virus is circulating in the communities where the trial takes place. It could take as many as 30,000 volunteers to get the answer, and the entire process will probably take months.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna gets further $472 million U.S. award for coronavirus vaccine developmentModerna said on Sunday it has received an additional $472 million from the U.S. government's Biomedical Advanced Research and Development Authority to support the development of its novel coronavirus vaccine.
Weiterlesen »
Moderna gets further $472 million U.S. award for coronavirus vaccine developmentModerna Inc said on Sunday it has received an additional $472 million from the U.S. government's Biomedical Advanced Research and Development Authority (BARDA) to support development of its novel coronavirus vaccine.
Weiterlesen »
Op-Ed: The U.S. stumbled badly with coronavirus testing. How will it distribute 300 million doses of vaccine?Op-Ed: The U.S. stumbled badly with coronavirus testing. How will it distribute 300 million doses of vaccine? (via latimesopinion)
Weiterlesen »
The world's biggest coronavirus vaccine study begins, a U.S. trial that will include 30,000 people to see if the shots really workThe world's biggest Covid-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government — one of several candidates in the final stretch of the global vaccine race.
Weiterlesen »